New drug aims to shorten hospital stays for MG patients
Disease control
Recruiting now
This study tests a daily injection called zilucoplan in 15 adults hospitalized with severe generalized myasthenia gravis (gMG). The goal is to see if the drug can quickly improve muscle weakness and daily activities within 2 weeks. Participants receive the treatment for 12 weeks,…
Phase: PHASE3 • Sponsor: Miriam Freimer • Aim: Disease control
Last updated May 14, 2026 12:04 UTC